Cellectar Biosciences (CLRB) Deferred Taxes (2010 - 2014)
Cellectar Biosciences (CLRB) posted Deferred Taxes of $1380.0 for Q1 2014, little changed sequentially from $1380.0 in Q4 2013, and down 37.13% YoY from $2195.0 in Q1 2013.
Cellectar Biosciences (CLRB) Deferred Taxes (2010 - 2014) Analysis & Trends
Cellectar Biosciences has reported Deferred Taxes for 5 years, with the latest figure at $1380.0 in Q1 2014.
- Quarterly Deferred Taxes fell 37.13% year-over-year to $1380.0 in Q1 2014, while the trailing twelve-month figure through Mar 2014 was $7015.0 (down 31.43% YoY) and the FY2017 annual result came in at -$7639.0, down 226.31% from the prior year.
- Deferred Taxes held at $1380.0 in Q1 2014 per CLRB's latest filing, from $1380.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $5208.0 in Q4 2010 and troughed at -$1191.0 in Q2 2011.
- A 5-year average of $2599.1 and a median of $2854.0 in 2012 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2011 and 2012: Deferred Taxes slumped 42.65% in 2011, then surged 350.8% in 2012.
- Over 5 years, Deferred Taxes stood at $5208.0 in 2010, then plunged by 42.65% to $2987.0 in 2011, then dropped by 26.51% to $2195.0 in 2012, then slumped by 37.13% to $1380.0 in 2013, then changed by 0.0% to $1380.0 in 2014.
- According to Business Quant data, Deferred Taxes over the past three periods registered $1380.0, $1380.0, and $2059.0 for Q1 2014, Q4 2013, and Q3 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Cellectar Biosciences | 6.75 Mn | 6.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 1,380.00 |
| Dec 31, 2013 | 1,380.00 |
| Sep 30, 2013 | 2,059.00 |
| Jun 30, 2013 | 2,196.00 |
| Mar 31, 2013 | 2,195.00 |
| Dec 31, 2012 | 2,195.00 |
| Sep 30, 2012 | 2,854.00 |
| Jun 30, 2012 | 2,987.00 |
| Mar 31, 2012 | 2,987.00 |
| Dec 31, 2011 | 2,987.00 |
| Sep 30, 2011 | 2,951.00 |
| Jun 30, 2011 | -1,191.00 |
| Mar 31, 2011 | 4,323.00 |
| Dec 31, 2010 | 5,208.00 |
| Sep 30, 2010 | 4,476.00 |